|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and noninterest bearing balances due from banks | ||||||||||||||||||||
| Interest bearing balances due from banks and federal funds sold | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Interest bearing balances due from banks - time | ||||||||||||||||||||
| Held-to-maturity, net of allowance for credit losses of $3,214 at December 31, 2024 | ||||||||||||||||||||
| Available-for-sale, (amortized cost of $3,439,526 and $3,642,809 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Mortgage loans held for sale | ||||||||||||||||||||
| Assets held in trading accounts | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Allowance for credit losses on loans | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Premises and equipment | ||||||||||||||||||||
| Foreclosed assets and other real estate owned | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest bearing transaction accounts | ||||||||||||||||||||
| Interest bearing transaction accounts and savings deposits | ||||||||||||||||||||
| Time deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal funds purchased and securities sold under agreements to repurchase | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Subordinated notes and debentures | ||||||||||||||||||||
| Accrued interest and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, Class A, $0.01 par value; 350,000,000 shares authorized at June 30, 2026 and December 31, 2025; 144,442,482 and 144,762,817 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Undivided profits | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
